Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

v3.20.2
NOTES PAYABLE (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Jul. 28, 2020
Nov. 30, 2020
Nov. 30, 2019
Nov. 30, 2018
Sep. 30, 2020
Sep. 30, 2020
Dec. 31, 2019
Debt Instrument [Line Items]              
Debt discount         $ 2,262,000 $ 2,262,000
Interest expenses         460,000 460,000 0
Fair Value, Inputs, Level 3 [Member]              
Debt Instrument [Line Items]              
Secured debt         17,857,000 17,857,000 0
Lenders [Member]              
Debt Instrument [Line Items]              
Debt discount         2,262,000 2,262,000  
Insurance Policy [Member]              
Debt Instrument [Line Items]              
Prepaid expenses         $ 0 $ 0 $ 923,292
Loan Agreement [Member]              
Debt Instrument [Line Items]              
Notes payable   $ 909,375 $ 963,514 $ 491,629      
Monthly principal and interest payments   $ 103,112 $ 109,413 $ 49,857      
Monthly loan payments term   nine-month period nine-month period ten-month period      
Annual interest rate   4.89% 5.25% 3.07%      
Loan repayment term description       This loan was fully repaid in August 2019      
Loan Agreement [Member] | K2 HealthVentures LLC [Member]              
Debt Instrument [Line Items]              
Annual interest rate 8.50%       8.50% 8.50%  
Secured debt $ 50,000,000       $ 21,190,000 $ 21,190,000  
Debt description The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.            
Debt maturity date Aug. 01, 2024            
Debt conversion per share $ 9.40            
Warrants to purchase shares of common stock, exercised 86,206            
Exercise price of warrants $ 6.96            
Proceeds from warrant $ 472,000            
Proceeds from prepayment and default features 546,000         757,000  
Debt issuance cost 1,244,000            
Final payment 1,190,000       $ 1,190,000 $ 1,190,000  
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Maximum [Member]              
Debt Instrument [Line Items]              
Debt conversion amount $ 5,000,000            
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Prime Rate [Member]              
Debt Instrument [Line Items]              
Annual interest rate 5.25%            
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche One [Member]              
Debt Instrument [Line Items]              
Secured debt $ 20,000,000            
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche Two [Member]              
Debt Instrument [Line Items]              
Secured debt 20,000,000            
Loan Agreement [Member] | K2 HealthVentures LLC [Member] | Share-based Payment Arrangement, Tranche Three [Member]              
Debt Instrument [Line Items]              
Secured debt $ 10,000,000            
Event of Default - Loan Agreement [Member] | K2 HealthVentures LLC [Member]              
Debt Instrument [Line Items]              
Annual interest rate         5.00% 5.00%